Treatment Failure in Urinary Tract Infections: A Warning Witness for Virulent Multi-Drug Resistant ESBL- Producing Escherichia coli

References

• Mazzulli T. Diagnosis and management of simple and complicated urinary tract infections (UTIs). Can J Urol. 2012;19(1):42–48.23089347
   PubMed Web of Science ®Google Scholar
• Munkhdelger Y, Gunregjav N, Dorjpurev A, et al. Detection of virulence genes, phylogenetic group and antibiotic resistance of uropathogenic Escherichia coli in Mongolia. J Infect Dev Ctries. 2017;11(01):51–57. doi:10.3855/jidc.790328141590
   PubMed Web of Science ®Google Scholar
• Tarchouna M, Ferjani A, Ben-Selma W, et al. Distribution of uropathogenic virulence genes in Escherichia coli isolated from patients with urinary tract infection. Int J Infect Dis. 2013;17(6):e450–453. doi:10.1016/j.ijid.2013.01.02523510539
   PubMed Web of Science ®Google Scholar
• Baby S, Karnaker VK, Geetha R. Adhesins of uropathogenic Escherichia coli (UPEC). Int J Med Microbiol Trop Dis. 2016;2(1):10–18.
   Google Scholar
• Paniagua-Contreras GL, Monroy-Perez E, Rodriguez-Moctezuma JR, et al. Virulence factors, antibiotic resistance phenotypes and O-serogroups of Escherichia coli strains isolated from community-acquired urinary tract infection patients in Mexico. J Microbiol Immunol Infect. 2017;50(4):478–485. doi:10.1016/j.jmii.2015.08.00526433755
   PubMedGoogle Scholar
• Frommel U, Lehmann W, Rodiger S, et al. Adhesion of human and animal Escherichia coli strains in association with their virulence-associated genes and phylogenetic origins. Appl Environ Microbiol. 2013;79(19):5814–5829. doi:10.1128/AEM.01384-1323872574
   PubMed Web of Science ®Google Scholar
• Demirel I, Kinnunen A, Önnberg A, et al. Comparison of host response mechanisms evoked by extended spectrum beta lactamase (ESBL)-and non-ESBL-producing uropathogenic E. coli. BMC Microbiol. 2013;13(1):181. doi:10.1186/1471-2180-13-18124059789
   PubMed Web of Science ®Google Scholar
• Derakhshandeh A, Firouzi R, Naziri Z. Phylogenetic group determination of faecal Escherichia coli and comparative analysis among different hosts. IJVR. 2014;15(1):13–17.
   Web of Science ®Google Scholar
• CLSI. Performance Standards for Antimicrobial Susceptibility Testing CLSI Supplement M100. 28th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2018.
   Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x21793988
   PubMed Web of Science ®Google Scholar
• Tabar MM, Mirkalantari S, Amoli RI. Detection of ctx-M gene in ESBL-producing E. coli strains isolated from urinary tract infection in Semnan, Iran. Electron Physician. 2016;8(7):2686–2690. doi:10.19082/268627648198
   PubMedGoogle Scholar
• Brinas L, Zarazaga M, Saenz Y, et al. Beta-lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals. Antimicrob Agents Chemother. 2002;46(10):3156–3163. doi:10.1128/AAC.46.10.3156-3163.200212234838
   PubMed Web of Science ®Google Scholar
• Rodriguez-Siek KE, Giddings CW, Doetkott C, et al. Comparison of Escherichia coli isolates implicated in human urinary tract infection and avian colibacillosis. Microbiology. 2005;151(Pt 6):2097–2110. doi:10.1099/mic.0.27499-015942016
   PubMed Web of Science ®Google Scholar
• Le Bouguenec C, Archambaud M, Labigne A. Rapid and specific detection of the pap, afa, and sfa adhesin-encoding operons in uropathogenic Escherichia coli strains by polymerase chain reaction. J Clin Microbiol. 1992;30(5):1189–1193. doi:10.1128/JCM.30.5.1189-1193.19921349900
   PubMed Web of Science ®Google Scholar
• Maurer JJ, Brown TP, Steffens WL, et al. The occurrence of ambient temperature-regulated adhesins, curli, and the temperature-sensitive hemagglutinin tsh among avian Escherichia coli. Avian Dis. 1998;42(1):106–118. doi:10.2307/15925829533087
   PubMed Web of Science ®Google Scholar
• Horne SM, Pfaff-McDonough SJ, Giddings CW, et al. Cloning and sequencing of the iss gene from a virulent avian Escherichia coli. Avian Dis. 2000;44(1):179–184. doi:10.2307/159252210737659
   PubMed Web of Science ®Google Scholar
• World Health Organization. Antimicrobial resistance: global report on surveillance. 2014 Available from: http://www.who.int/drugresistance/documents/surveillancereport/en.
   Google Scholar
• Rezaei-Tavirani M, Ghafourian S, Sayehmiri F, et al. Prevalence of cotrimoxazole resistance uropathogenic bacteria in Iran: a systematic review and meta-analysis. Arch Clin Infect Dis. 2018;13(5):e63256.
   Web of Science ®Google Scholar
• Derakhshan S, Pourzare M, Roshani D. Distribution of virulence factors according to antibiotic susceptibility among Escherichia coli isolated from urinary tract infection. Indian J Nephrol. 2018;28(3):191–197. doi:10.4103/ijn.IJN_30_1729962668
   PubMed Web of Science ®Google Scholar
• Ali I, Rafaque Z, Ahmed S, et al. Prevalence of multi-drug resistant uropathogenic Escherichia coli in Potohar region of Pakistan. Asian Pac J Trop Biomed. 2016;6(1):60–66. doi:10.1016/j.apjtb.2015.09.022
   Web of Science ®Google Scholar
• Ramirez-Castillo FY, Moreno-Flores AC, Avelar-Gonzalez FJ, et al. An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study. Ann Clin Microbiol Antimicrob. 2018;17(1):34. doi:10.1186/s12941-018-0286-530041652
   PubMed Web of Science ®Google Scholar
• Lee DS, Lee SJ, Choe HS. Community-acquired urinary tract infection by Escherichia coli in the era of antibiotic resistance. Biomed Res Int. 2018;2018:7656752. doi:10.1155/2018/765675230356438
   PubMed Web of Science ®Google Scholar
• Hashemizadeh Z, Kalantar-Neyestanaki D, Mansouri S. Clonal relationships, antimicrobial susceptibilities, and molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli isolates from urinary tract infections and fecal samples in Southeast Iran. Rev Soc Bras Med Trop. 2018;51(1):44–51. doi:10.1590/0037-8682-0080-201729513841
   PubMed Web of Science ®Google Scholar
• Briongos-Figuero LS, Gomez-Traveso T, Bachiller-Luque P, et al. Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing enterobacteria. Int J Clin Pract. 2012;66(9):891–896. doi:10.1111/j.1742-1241.2012.02991.x22897466
   PubMed Web of Science ®Google Scholar
• Azap OK, Arslan H, Serefhanoglu K, et al. Risk factors for extended-spectrum β-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clin Microbiol Infect. 2010;16(2):147–151. doi:10.1111/j.1469-0691.2009.02941.x19689464
   PubMed Web of Science ®Google Scholar
• Calbo E, Romani V, Xercavins M, et al. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum β-lactamases. J Antimicrob Chemother. 2006;57(4):780–783. doi:10.1093/jac/dkl03516492721
   PubMed Web of Science ®Google Scholar
• Bartoloni A, Sennati S, Di Maggio T, et al. Antimicrobial susceptibility and emerging resistance determinants (bla CTX-M, rmtB, fosA3) in clinical isolates from urinary tract infections in the Bolivian Chaco. Int J Infect Dis. 2016;43:1–6. doi:10.1016/j.ijid.2015.12.00826686940
   PubMed Web of Science ®Google Scholar
• Derakhshandeh A, Firouzi R, Motamedifar M, et al. Distribution of virulence genes and multiple drug-resistant patterns amongst different phylogenetic groups of uropathogenic Escherichia coli isolated from patients with urinary tract infection. Lett Appl Microbiol. 2015;60(2):148–154. doi:10.1111/lam.1234925355175
   PubMed Web of Science ®Google Scholar
• Rodriguez-Bano J, Navarro MD, Romero L, et al. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol. 2004;42(3):1089–1094. doi:10.1128/JCM.42.3.1089-1094.200415004058
   PubMed Web of Science ®Google Scholar
• Yasir M, Ajlan AM, Shakil S, et al. Molecular characterization, antimicrobial resistance and clinico-bioinformatics approaches to address the problem of extended-spectrum β-lactamase-producing Escherichia coli in western Saudi Arabia. Sci Rep. 2018;8(1):14847. doi:10.1038/s41598-018-33093-830287889
   PubMed Web of Science ®Google Scholar
• Sanchez GV, Master RN, Karlowsky JA, et al. In vitro antimicrobial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010. Antimicrob Agents Chemother. 2012;56(4):2181–2183. doi:10.1128/AAC.06060-1122252813
   PubMed Web of Science ®Google Scholar
• Karlowsky JA, Hoban DJ, Decorby MR, et al. Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study. Antimicrob Agents Chemother. 2006;50(6):2251–2254. doi:10.1128/AAC.00123-0616723598
   PubMed Web of Science ®Google Scholar
• Derakhshandeh A, Firouzi R, Motamedifar M, et al. Virulence characteristics and antibiotic resistance patterns among various phylogenetic groups of uropathogenic Escherichia coli isolates. Jpn J Infect Dis. 2015;68(5):428–431. doi:10.7883/yoken.JJID.2014.32725866111
   PubMed Web of Science ®Google Scholar
• Oliveira FA, Paludo KS, Arend LN, et al. Virulence characteristics and antimicrobial susceptibility of uropathogenic Escherichia coli strains. Genet Mol Res. 2011;10(4):4114–4125. doi:10.4238/2011.October.31.522057993
   PubMed Web of Science ®Google Scholar
• Zhao L, Chen X, Zhu X, et al. Prevalence of virulence factors and antimicrobial resistance of uropathogenic Escherichia coli in Jiangsu province (China). Urology. 2009;74(3):702–707. doi:10.1016/j.urology.2009.01.04219362346
   PubMed Web of Science ®Google Scholar
• Tabasi M, Karam MR, Habibi M, et al. Genotypic characterization of virulence factors in Escherichia coli isolated from patients with acute cystitis, pyelonephritis and asymptomatic bacteriuria. J Clin Diagn Res. 2016;10(12):Dc01–dc7. doi:10.7860/JCDR/2016/21379.9009
   Google Scholar
• Santo E, Macedo C, Marin JM. Virulence factors of uropathogenic Escherichia coli from a university hospital in Ribeirao Preto, Sao Paulo, Brazil. Rev Inst Med Trop Sao Paulo. 2006;48(4):185–188. doi:10.1590/S0036-4665200600040000217119672
   PubMedGoogle Scholar
• Cordeiro MA, Werle CH, Milanez GP, et al. Curli fimbria: an Escherichia coli adhesin associated with human cystitis. Braz J Microbiol. 2016;47(2):414–416. doi:10.1016/j.bjm.2016.01.02426991275
   PubMed Web of Science ®Google Scholar
• Bien J, Sokolova O, Bozko P. Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage. Int J Nephrol. 2012;2012:681473. doi:10.1155/2012/68147322506110
   PubMedGoogle Scholar
• Jalali HR, Pourbakhsh A, Fallah F, et al. Genotyping of virulence factors of uropathogenic Escherichia coli by PCR. Novel Biomed. 2015;3(4):177–181.
   Google Scholar
• Terlizzi ME, Gribaudo G, Maffei ME. UroPathogenic Escherichia coli (UPEC) infections: virulence factors, bladder responses, antibiotic, and non-antibiotic antimicrobial strategies. Front Microbiol. 2017;8:1566. doi:10.3389/fmicb.2017.0156628861072
   PubMed Web of Science ®Google Scholar